fluorodeoxyglucose f18 has been researched along with a-Synucleinopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carli, G; de Jong, BM; Ferini-Strambi, L; Galbiati, A; Leenders, KL; Meles, SK; Padovani, A; Perani, D; Pilotto, A; Reesink, FE | 1 |
| Centonze, D; Chiaravalloti, A; Izzi, F; Liguori, C; Mercuri, NB; Modugno, N; Olivola, E; Pierantozzi, M; Placidi, F; Ruffini, R; Schillaci, O; Stefani, A | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and a-Synucleinopathies
| Article | Year |
|---|---|
Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
Topics: Alzheimer Disease; Brain; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Multiple System Atrophy; Multivariate Analysis; Parkinson Disease; Positron-Emission Tomography; Synucleinopathies | 2023 |
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study.
Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Synucleinopathies; Tauopathies | 2019 |